Jean-Pierre Venetz

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


95 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 |
 
Prise en charge des maladies rénales génétiques : expérience locale et importance du réseau [Management of genetic renal disorders: local experience and importance of the network]
Bonny O., Ketterer A., Hermida S., Superti-Furga A., Venetz J.P., Chehade H., Fodstad H., Cina V., Parvex P., Paoloni-Giacobino A. et al., 2023/06/21. Revue medicale suisse, 19 (832) pp. 1245-1249. Peer-reviewed.
Incidence, Risk Factors, and Management of Incisional Hernias After Kidney Transplant: A 20-Year Single Center Experience.
Costa L., Martin D., Zingg T., Venetz J.P., Demartines N., Golshayan D., Matter M., 2023/03. Transplantation proceedings, 55 (2) pp. 337-341. Peer-reviewed.
Pregnancy after kidney transplantation: an observational study on maternal, graft and offspring outcomes in view of current literature.
Stavart L., Verly C., Venetz J.P., Baud D., Legardeur H., Vial Y., Golshayan D., 2023. Frontiers in nephrology, 3 p. 1216762. Peer-reviewed.
Differences Between Centers in Psychosocial Evaluations for Living Kidney Donors Do Not Influence Outcome: Results From an Observational Multicenter Study.
Ludwig G., Geiger I., Götzmann L., Jordan K.D., Döbbel S., Klaghofer R., Salathé M., Stillhard U., Meinlschmidt G., Kiss A. et al., 2022/12. Transplantation direct, 8 (12) pp. e1400. Peer-reviewed.
Predictive Factors of Surgical Complications in the First Year Following Kidney Transplantation.
Salamin P., Deslarzes-Dubuis C., Longchamp A., Petitprez S., Venetz J.P., Corpataux J.M., Déglise S., 2022/07. Annals of vascular surgery, 83 pp. 142-151. Peer-reviewed.
Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series.
Halfon M., Stavart L., Venetz J.P., Manuel O., Golshayan D., 2022. Transplant international, 35 p. 10716. Peer-reviewed.
 
COVID-19 as a potential trigger of complement-mediated atypical HUS.
El Sissy C., Saldman A., Zanetta G., Martins P.V., Poulain C., Cauchois R., Kaplanski G., Venetz J.P., Bobot M., Dobosziewicz H. et al., 2021/11/04. Blood, 138 (18) pp. 1777-1782. Peer-reviewed.
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.
Guzzo G., Sadallah S., Fodstad H., Venetz J.P., Rotman S., Teta D., Gauthier T., Pantaleo G., Superti-Furga A., Pascual M., 2021. Frontiers in genetics, 12 p. 529236. Peer-reviewed.
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
Perrottet N., Fernández-Ruiz M., Binet I., Dickenmann M., Dahdal S., Hadaya K., Müller T., Schaub S., Koller M., Rotman S. et al., 2021. PloS one, 16 (4) pp. e0250829. Peer-reviewed.
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Schwotzer N., Paganetti G., Barchi M., Perrottet N., Aubert V., Sadallah S., Rotman S., Venetz J.P., Matter M., Golshayan D. et al., 2020/07. Xenotransplantation, 27 (4) pp. e12630. Peer-reviewed.
Impact of kidney transplantation on sleep apnea severity: A prospective polysomnographic study.
Forni Ogna V., Ogna A., Haba-Rubio J., Nowak G., Venetz J.P., Golshayan D., Matter M., Burnier M., Pascual M., Heinzer R., 2020/06. American journal of transplantation, 20 (6) pp. 1659-1667. Peer-reviewed.
Infection à SARS-CoV-2 et transplantation d’organes solides [SARS-CoV-2 infection and solid organ transplantation]
Golshayan D., Aubert J.D., Hullin R., Moradpour D., Venetz J.P., Manuel O., Pascual M., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 815-818. Peer-reviewed.
Syndrome d’Alagille [Alagille Syndrome]
Wakim El-Khoury J., Venetz J.P., Rutz T., Sciarra A., Unger S., Sempoux C., Moradpour D., Fraga M., 2019/08/28. Revue medicale suisse, 15 (660) pp. 1506-1510. Peer-reviewed.
 
Variations et anomalies néphrologiques, vasculaires et urologiques chez les candidats au don vivant rénal [Renal, vascular and urological variations and abnormalities in living kidney donor candidates]
Costa A., Matter M., Pascual M., Doerfler A., Venetz J.P., 2019/03. Progres en urologie, 29 (3) pp. 166-172. Peer-reviewed.
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
Quteineh L., Wójtowicz A., Bochud P.Y., Crettol S., Vandenberghe F., Venetz J.P., Manuel O., Golshayan D., Lehmann R., Mueller N.J. et al., 2019/01. American journal of transplantation, 19 (1) pp. 238-246. Peer-reviewed.
 
Use of Intraoperative Duplex Ultrasound and Resistance Index Reduces Complications in Living Renal Donor Transplantation.
Bejic M., Déglise S., Venetz J.P., Nseir G., Dubuis C., Saucy F., Berard X., Meuwly J.Y., Corpataux J.M., 2018/12. Transplantation proceedings, 50 (10) pp. 3192-3198. Peer-reviewed.
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Muller Y.D., Ghaleb N., Rotman S., Vionnet J., Halfon M., Catana E., Golshayan D., Venetz J.P., Aubert V., Pascual M., 2018/04. Transplant international, 31 (4) pp. 451-455. Peer-reviewed.
Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature.
Kheir V., Dirani A., Halfon M., Venetz J.P., Halabi G., Guex-Crosier Y., 2017/11/22. BMC ophthalmology, 17 (1) p. 207. Peer-reviewed.
 
Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.
Gero D., Dib F., Matter M., Pascual M., Venetz J.P., Demartines N., Melloul E., 2017/11. World journal of surgery, 41 (11) pp. 2940-2948. Peer-reviewed.
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L., Bochud P.Y., Golshayan D., Crettol S., Venetz J.P., Manuel O., Kutalik Z., Treyer A., Lehmann R., Mueller N.J. et al., 2017/01. The pharmacogenomics journal, 17 (1) pp. 69-75. Peer-reviewed.
 
Oral valganciclovir for CMV gastritis.
Saouli A.C., Salvade I., Saldarriaga J., Manuel O., Venetz J.P., Golshayan D., Sempoux C., Pascual M., 2016/09. Clinics and research in hepatology and gastroenterology, 40 (4) pp. e50-1. Peer-reviewed.
 
Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.
Salvadé I., Aubert V., Venetz J.P., Golshayan D., Saouli A.C., Matter M., Rotman S., Pantaleo G., Pascual M., 2016/06. Human immunology, 77 (6) pp. 483-489. Peer-reviewed.
Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?
Michaud L., Ludwig G., Berney S., Rodrigues S., Niquille A., Santschi V., Favre A.S., Lange A.C., Michels A.A., Vrijens B. et al., 2016. Pharmacy practice, 14 (4) p. 822. Peer-reviewed.
 
Continuous subcutaneous insulin pump treatment associated with absence of recurrent kidney allograft diabetic nephropathy.
Halfon M., Rotman S., Egli M., Venetz J.P., Pascual M., 2015. Acta Diabetologica, 52 (6) pp. 1175-1177. Peer-reviewed.
 
Transition en transplantation rénale [Transition in kidney transplantation].
Chehade H., Parvex P., Venetz J.P., Hadaya K., Typaldou S.A., Villard E., Vogeleisen C., Pilon N., Cachat F., Pascual M., 2015. Revue Médicale Suisse, 11 (462) pp. 456, 458-456, 460. Peer-reviewed.
 
Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
Vermeiren P., Aubert V., Sugamele R., Aubert J.D., Venetz J.P., Meylan P., Pascual M., Manuel O., 2014. Transplant International, 27 (9) pp. 903-908.
 
Evolving Trends in the Costs Associated With Hospital Use of Immunosuppressive Drugs.
Perrottet N., Aubert V., Venetz J.P., Ugolini E., Matter M., Pannatier A., Pascual M., 2013. Transplantation, 95 (5) pp. e24-e25.
 
Glucosurie rénale [Renal glucosuria].
Rohfleisch A., Nseir G., Chehade H., Noverraz M.G., Venetz J.P., Barbey F., 2013. Revue Médicale Suisse, 9 (378) pp. 636-640.
 
MR imaging as a specific diagnostic tool for bilateral microcysts in chronic lithium nephropathy.
Golshayan D., Nseir G., Venetz J.P., Pascual M., Barbey F., 2012/03. Kidney International, 81 (6) p. 601. Peer-reviewed.
Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease.
Friedrich L., Barbey F., Pascual M., Venetz J.P., 2012. Case Reports in Transplantation, 2012 p. 513025.
 
Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient.
Chehade H., Girardin E., Delich V., Pascual M.A., Venetz J.P., Cachat F., 2012. Transplant Infectious Disease, 14 (4) pp. E27-E29.
Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient
Renard D., Gauthier T., Venetz J.-P., Buclin T., Kuntzer T., 2012. Clinical Kidney Journal, 5 (4) pp. 323-326. Peer-reviewed.
 
Rejets aigus
Venetz J.P., Pascual M., 2012. pp. 449-464 dans Legendre C. (eds.) Transplantation Rénale chap. 38, Médecine Sciences Publications.
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients.
Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.A., Venetz J.P., Calandra T., Cavassini M., 2011. Clinical Infectious Diseases, 52 (2) pp. 248-256.
 
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
Boillat Blanco N., Pascual M., Venetz J.P., Nseir G., Meylan P.R., Manuel O., 2011. Transplantation, 91 (2) pp. 251-255.
 
Incidence of Infectious Complications in Kidney Transplant Recipients Receiving Induction with Basiliximab, Thymoglobulin or Both
Jankovic J., Pascual M., Venetz J.P., Nseir G., Meylan P., Manuel O., 2011. p. 323 dans ATC 2011, American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Monitoring of CD4(+)CD25(high)IL-7R alpha(high) activated T Cells in Kidney Transplant Recipients
Vallotton L., Hadaya K., Venetz J.P., Buehler L.H., Ciuffreda D., Nseir G., Codarri L., Villard J., Pantaleo G., Pascual M., 2011. Clinical Journal of the American Society of Nephrology, 6 (8) pp. 2025-2033.
 
Renal transplantation following aorto-iliac reconstruction is a safe a strategy
Dubuis C., Deglise S., Saucy F., Saint-Lebes B., Venetz J.P., Pascual M., Corpataux J.M., 2011. p. 284 dans 15th Congress of the European Society for Organ Transplantation and 22nd Annual Conference of the British Society for Histocompatibility and Immunogenetics, Transplant international. Peer-reviewed.
 
Ganciclovir exposure under a 450mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Meylan P.R., 2010. Clinical Transplantation, 24 (6) pp. 794-800.
 
Giant warts in a kidney transplant patient: regression with sirolimus.
Kostaki M., Venetz J.P., Nseir G., Meylan P., Sahli R., Pascual M., Laffitte E., 2010. British Journal of Dermatology, 162 (5) pp. 1148-1150.
 
Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient.
Mani L.Y., Nseir G., Venetz J.P., Pascual M., 2010. Transplantation, 90 (7) pp. 804-805.
 
Treatment of antibody-mediated rejection in kidney transplantation
Venetz J.P., Pascual M., 2010. pp. 35-39 dans Grinyo J.M., Vulto A.G. (eds.) Transplantation for European hospital pharmacists, Pharma Publishing and Media Europe.
Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.
Perrottet Nancy, Manuel Oriol, Lamoth Frederic, Venetz Jean-Pierre, Sahli Roland, Decosterd Laurent A., Buclin Thierry, Pascual Manuel, Meylan Pascal, 2010. BMC Infectious Diseases, 10 p. 2.
 
Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant?
Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Transplantation, 87 (12) pp. 1897-1898.
 
Donors/recipients representations about living-kidney donation : P-527
Pralong L., Pascual M., Santiago M., Venetz J.P., Piot-Ziegler C., 2009. p. 226 dans 14th Congress of the European Society for Organ Transplantation, Transplant International. Peer-reviewed.
 
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplant recipients: a prospective study : P125
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L., Buclin T., Meylan P., 2009. pp. 32S-33S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.
 
Ganciclovir Exposure under a 450 mg Daily Dosage of Valganciclovir for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients.
Manuel Oriol, Pascual Manuel, Perrottet Nancy, Lamoth Frederic, Venetz Jean-Pierre, Decosterd Laurent, Buclin Thierry, Meylan Pascal R., 2009. p. 249 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
 
Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients.
Hadaya K., Ferrari-Lacraz S., Giostra E., Majno P., Moll S., Rubbia-Brandt L., Marangon N., Venetz J.P., Bolle J.F., Mentha G. et al., 2009. Transplant International, 22 (2) pp. 242-246. Peer-reviewed.
 
Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Human Immunology, 70 (8) pp. 580-583.
No detectable indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Lamoth Frédéric, Manuel Oriol, Venetz Jean-Pierre, Faouzi Mohamed, Meylan Pascal, Pascual Manuel, 2009. pp. IMI-3, p. 62 dans Genes and Diseases, CHUV Research Day, January 29, 2009, Université de Lausanne, Faculté de biologie et de médecine.
 
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.
Perrottet N., Csajka C., Pascual M., Manuel O., Lamoth F., Meylan P., Aubert J.D., Venetz J.P., Soccal P., Decosterd L.A. et al., 2009. Antimicrobial agents and chemotherapy, 53 (7) pp. 3017-23.
 
Short-course thymoglobulin induction and steroid-free immunosuppressive regimen in renal transplantation
Hadaya K., Venetz J.P., Ponte B., Vallotton L., Buhler L., Pascual M., Martin P.Y., 2009. pp. 6S dans Annual meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
The role of I-123-hippuran(OIH) renography (RG) in the presurgical, work-up of laparoscopic live kidney donors : SS421
Nicod Lalonde M., Venetz J.P., Matter M., Qanadli S., Bischof Delaloye A., 2009. dans SGR-SSR 2009, 96th Annual Swiss Congress of Radiology.
 
Usefulness of a routine monitoring of cytomegalovirus viremia after discontinuation of antiviral prophylaxis in kidney transplantation : P117
Boillat N., Pascual M., Venetz J.P., Meylan P.R, Manuel O., 2009. pp. 31S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.
 
Cost effectiveness of a new combined immunosuppressive and antiviral regimen on the one-year follow-up of kidney transplant patients.
Manuel Oriol, Kast-Bruechner Mira, Venetz Jean-Pierre, Meylan Pascal R., Pascual Manuel, Wasserfallen Jean-Blaise, 2008. pp. 395-395 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation.
Wasserfallen J.B., Kast-Brückner M., Manuel O., Venetz J.P., Meylan P.R., Pascual M., 2008. International Journal of Technology Assessment In Health Care, 24 (3) pp. 312-317.
 
Cytomegalovirus infection and new-onset post-transplant diabetes mellitus.
Leung Ki E.L., Venetz J.P., Meylan P., Lamoth F., Ruiz J., Pascual M., 2008. Clinical Transplantation, 22 (2) pp. 245-249.
 
Disposition of oral valganciclovir during continuous renal replacement therapy in two lung transplant recipients
Perrottet Nancy, Robatel Corinne, Meylan Pascal, Pascual Manuel, Venetz Jean-Pierre, Aubert John-David, Berger Mette M., Decosterd Laurent A., Biollaz Jerome, Buclin Thierry, 2008. p. 566 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
Perrottet N., Robatel C., Meylan P., Pascual M., Venetz J.P., Aubert J.D., Berger M.M., Decosterd L.A., Buclin T., 2008. Journal of Antimicrobial Chemotherapy, 61 (6) pp. 1332-1335.
 
Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Fontana Massimiliano, Aubert John-David, Ansermot Nicolas, Fathi Marc, Pascual Manuel, Eap Chin-Bin, 2008. Pharmacogenetics and Genomics, 18 (4) pp. 307-315. Peer-reviewed.
 
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Lamoth Frederic, Pascual Manuel, Erard Veronique, Venetz Jean-Pierre, Nseir Ghaleb, Meylan Pascal, 2008. Antiviral Therapy, 13 (8) pp. 1001-1009. Peer-reviewed.
 
Low-dose valganciclovir is efficacious and safe for prophylaxis of cytomegalovirus infection in kidney transplantation
Perrottet Nancy, Manuel Oriol, Venetz Jean-Pierre, Lamoth Frederic, Decosterd Laurent A., Buclin Thierry, Biollaz Jerome, Meylan Pascal, Pascual Manuel, 2008. pp. 565-566 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Laffitte E., Venetz J.P., Aubert J.D., Duchosal M.A., Panizzon R.G., Pascual M., 2008. Dermatology, 217 (1) pp. 87-88.
 
No detectable indirect effects of late-onset Cytomegalovirus disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Lamoth Frederic, Manuel Criol, Meylan Pascal R., Venetz Jean-Pierre, Faouzi Mohammed, Pascual Manuel, 2008. pp. S13 dans Abstracts of the 15th International Symposium on Infections in the Immunocompromised Host, International Journal of Infectious Diseases. Peer-reviewed.
 
No evidence of indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Manuel Oriol, Lamoth Frederic, Meylan Pascal R., Fellay Jacques, Venetz Jean-Pierre, Pascual Manuel, 2008. p. 527 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Prospective monitoring of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population after first kidney transplantation following thymoglobulin or basiliximab induction
Vallotton Laure, Hadaya Karine, Ciuffreda Donatella, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Prospective monitoring of a CD4+ CD25high CD45RO+ CD127high T-cell population after first kidney transplantation following thymoglobulin or basiliximab induction
Vallotton L., Hadaya K., Buhler L., Ciuffreda D., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Quality of life transformations before and after kidney transplantation: A prospective qualitative study.
Piot-Ziegler Chantal, Szymanski Jennifer, Ruffiner-Boner Nadja, Weigand Isabelle, Santiago Marie, Venetz Jean-Pierre, Pascual Manuel, 2008. pp. 400-401 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Spontaneous discourse on employment status and professional identity of patients waiting for solid organ transplantation
Fonjallaz F., Fasseur F., Ruffiner-Boner N., Cuttelod T., Szymanski J., Santiago M., Pilon N., Venetz J.P., Pascual M., Piot-Ziegler C., 2008. pp. 488-495 dans Weimar W., Bos M.A., Busschbach J.J. (eds.) Organ Transplantation: Ethical, Legal and Psychosocial Aspects. Towards a Common European Policy, Pabst Science Publishers.
 
Switch to Sirolimus-based immunosuppresion in stable renal transplant recipients
Nseir G., Venetz J.P, Hadaya K., Buhler L., Martin P.Y., Pascual M., 2008. pp. 18S dans 40th Annual Meeting Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
The presence of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population correlates with the clinical status of kidney transplant recipients
Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Hadaya Karine, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
The presence of a CD4+ CD25high CD45RO+ CD127high T-cell population correlates with the clinical status of kidney transplant recipients
Vallotton L., Codarri L., Ciuffreda D., Hadaya K., Buhler L., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Treatment of antibody-mediated rejection in kidney transplantation
Venetz J.P., Pascual M., 2008. EJHP Practice, 14 (5) pp. 21-24.
 
What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?
Lamoth F., Manuel O., Venetz J.P., Faouzi M., Meylan P., Pascual M., 2008. Transplantation, 86 (9) pp. 1323-1324.
 
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
Manuel O., Venetz J.P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., Matter M., Meylan P.R., Pascual M., 2007/12/01. Swiss medical weekly, 137 (47-48) pp. 669-676. Peer-reviewed.
 
Role du pathologiste dans la pathologie renale. [The crucial role of the pathologist in renal disease]
Rotman S., Venetz J. P., Vogt B., 2007/07. Revue Médicale Suisse, 3 (119) pp. 1723-5.
 
New treatments for acute humoral rejection of kidney allografts.
Venetz J.P., Pascual M., 2007/05. Expert Opinion on Investigational Drugs, 16 (5) pp. 625-633.
 
Cost-effectiveness of a new combined immunosupressive regimen in kidney transplantation
Wasserfallen Jean-Blaise, Kast-Brückner Mira, Manuel Oriol, Venetz Jean-Pierre, Meylan Pascal, Pascual Manuel, 2007. pp. 40S dans Annual Conference of the Swiss Respiratory Society, Swiss Medical Weekly. Peer-reviewed.
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
Manuel O., Venetz J.P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., Matter M., Meylan P.R., Pascual M., 2007. Swiss Medical Weekly, 137 (47-48) pp. 669-676. Peer-reviewed.
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.
Codarri L., Vallotton L., Ciuffreda D., Venetz J.P., Garcia M., Hadaya K., Buhler L., Rotman S., Pascual M., Pantaleo G., 2007. Journal of Experimental Medicine, 204 (7) pp. 1533-1541. Peer-reviewed.
 
Identification of an expanded population of activated CD4(+) CD25(+) T cells expressing CD45RO and IL-7R in kidney transplant recipients
Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2007. p. 153 dans 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization, Transplant International. Peer-reviewed.
 
Pharmacokinetic and pharmacodynamic assessement of valganciclovir in the prophylaxis and treatment of CMV disease in solid organ transplant patients
Manuel O., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Pascual M., Meylan P., 2007. pp. 9S dans Annual Conference Swiss Society for Paediatrics, Swiss Medical Weekly. Peer-reviewed.
 
Psychological transformations in kidney transplantation: A prospective qualitative study
Piot-Ziegler Chantal, Szymanski Jennifer, Ruffiner-Boner Nadja, Fasseur Fabienne, Maillefer Julia, Weigand Isabelle, Venetz Jean-Pierre, Santiago Marie, Pascual Manuel, 2007. p. 181 dans 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization, Transplant International. Peer-reviewed.
 
De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin.
Rotman S., Déruaz C., Venetz J.P., Chaubert P., Benhattar J., Meuwly J.Y., Jichlinski P., Guillou L., Moll S., Pascual M. et al., 2006. Human Pathology, 37 (4) pp. 481-487.
 
Genetic polymorphisms of CYP3A genes affect cyclosporine a blood concentration and dose requirement in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Aubert John-David, Fontana Massimiliano, Brocard Murielle, Pascual Manuel, Eap Chin-Bin, 2006. p. 197 dans NA, Transplantation. Peer-reviewed.
 
Influence of MDR1 genetic polymorphisms on intralymphocyte concentrations of cyclosporine A in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Aubert John-David, Fontana Massimiliano, Ansermot Nicolas, Fathi Marc, Brocard Murielle, Pascual Manuel, Eap Chin-Bin, 2006. p. 197 dans NA, Transplantation. Peer-reviewed.
 
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin (MBL) deficiency
Manuel O., Tarr R., Venetz J.P., Trandelenburg M., Meylan P., Pascual M., 2006. pp. S16 dans 12th International Society for infectious Diseases, International Journal of Infectious Diseases. Peer-reviewed.
 
Oral valganciclovir prophylaxis in kidney transplant recipients
Manuel O., Fellay J., Venetz J.P., Sturzenegger N., Meylan R., Pascual M., 2006. pp. S16 dans 12th International Society for infectious Diseases, International Journal of Infectious Diseases. Peer-reviewed.
 
Pharmacokinetic and pharmacodynamic evaluation of valganciclovir in solid organ transplant patients
Manuel O., Perrottet N., Venetz J.P., Decosterd L.A., Buclin T., Pascual M., Meylan P., 2006. pp. S19 dans 12th International Society for infectious Diseases, International Journal of Infectious Diseases. Peer-reviewed.
 
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?
Wong W., Venetz J.P., Tolkoff-Rubin N., Pascual M., 2005/08. Transplantation, 80 (3) pp. 289-296.
 
Chirurgie viscérate chez le patient greffé ou en attente d'une transplantation [Visceral surgery in organ transplant recipients or in patients awaiting transplantation].
Matter M., Saucy F., Venetz J.P., Pascual M., 2005. Revue Médicale Suisse, 1 (24) pp. 1608-1615.
 
Sirolimus-induced acneiform eruption.
Kunzle N., Venetz J.P., Pascual M., Panizzon R.G., Laffitte E., 2005. Dermatology, 211 (4) pp. 366-369.
 
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.
Fellay J., Venetz J.P., Pascual M., Aubert J.D., Seudoux C., Meylan P.R., 2005. American Journal of Transplantation, 5 (7) pp. 1781-2; author reply 1783.
 
Dual transplant of marginal kidneys. Case report and review of the literature.
Matter M., Venetz J.P., Aubert V., Gachet C., Burnier M., Barbey F., 2003. Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera, 9 (5) pp. 213-215.
 
Protéinurie orthostatique et phénomène de compression de la veine rénale gauche (nutcracker syndrome) [Orthostatic proteinuria and compression of the left renal vein (nutcracker syndrome)]
Barbey F., Venetz J.P., Calderari B., Nguyen Q.V., Meuwly J.Y., 2003. Presse Médicale, 32 (19) pp. 883-885. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University